As at December 20, 2024Show prices
SaskWorks Diversified (Class A - Series A) - 27.7679
SaskWorks Diversified (Class A - Series B) - 30.2027
SaskWorks Diversified (Class A - Series F) - 33.4758
SaskWorks Resources (Class R - Series A) - 26.9087
SaskWorks Resources (Class R - Series B) - 35.2980
SaskWorks Resources (Class R - Series F) - 30.0734
CanniMed Therapeutics Inc. (CMED.TO) (“CanniMed” or the “Company”) announced today that its directors have approved the commencement of a capital project to increase its current cannabinoid oils processing capacity by constructing a new facility on the Company’s Saskatchewan campus…
CanniMed Therapeutics Inc. (TSX: CMED) (“CMED” or the “Company”), announces, in accordance with the Toronto Stock Exchange requirements, the voting results from its Annual General Meeting held Wednesday, April 19, 2017 in Saskatoon, Saskatchewan…
Please select the option that best describes you: